Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C

By Norton P.M.   Wells J.M.   Brown H.W.G.   Macpherson A.M.   Le Page R.W.F.  

Vaccine, Vol. 15, Iss. 6, 1997-04 ,pp. : 616-619

Elsevier

Access to resources Recommend Favorite

Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis

By Maassen C.B.M.   Laman J.D.   Heijne den Bak-Glashouwer M.J.   Tielen F.J.   van Holten-Neelen J.C.P.A.   Hoogteijling L.   Antonissen C.   Leer R.J.   Pouwels P.H.   Boersma W.J.A.   Shaw D.M.  

Vaccine, Vol. 17, Iss. 17, 1999-04 ,pp. : 2117-2128

Elsevier

Access to resources Recommend Favorite

Tetanus toxin fragment C-specific priming by intranasal infection with recombinant Bordetella pertussis

By Reveneau N.   Alonso S.   Jacob-Dubuisson F.   Mercenier A.   Locht C.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 926-933

Elsevier

Access to resources Recommend Favorite

Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies

By Yasuda Y.   Isaka M.   Taniguchi T.   Zhao Y.   Matano K.   Matsui H.   Morokuma K.   Maeyama J.-i.   Ohkuma K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2954-2963

Elsevier

Access to resources Recommend Favorite

Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit

By Isaka M.   Yasuda Y.   Kozuka S.   Miura Y.   Taniguchi T.   Matano K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 16, Iss. 17, 1998-10 ,pp. : 1620-1626

Elsevier

Access to resources Recommend Favorite